Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Non-Current Assets: 2014-2025

Historic Non-Current Assets for AC Immune (ACIU) over the last 12 years, with Sep 2025 value amounting to $72.3 million.

  • AC Immune's Non-Current Assets rose 10.61% to $72.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.3 million, marking a year-over-year increase of 10.61%. This contributed to the annual value of $72.3 million for FY2025, which is N/A change from last year.
  • According to the latest figures from FY2025, AC Immune's Non-Current Assets is $72.3 million, which was up 107,443.01% from $67,257 recorded in FY2024.
  • AC Immune's 5-year Non-Current Assets high stood at $72.3 million for FY2025, and its period low was $65,004 during FY2023.
  • For the 3-year period, AC Immune's Non-Current Assets averaged around $24.2 million, with its median value being $67,257 (2024).
  • As far as peak fluctuations go, AC Immune's Non-Current Assets skyrocketed by 734.38% in 2021, and later slumped by 99.89% in 2023.
  • AC Immune's Non-Current Assets (Yearly) stood at $64.4 million in 2021, then decreased by 6.70% to $60.0 million in 2022, then plummeted by 99.89% to $65,004 in 2023, then rose by 3.47% to $67,257 in 2024, then reached $72.3 million in 2025.